Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 39 Records) |
| Query Trace: Myocardial Infarction and ABCB1[original query] |
|---|
| Effect of paraoxonase-1 polymorphism on clinical outcomes in patients treated with clopidogrel after an acute myocardial infarction. Clinical pharmacology and therapeutics 2011 Oct 90 (4): 561-7. Simon T, Steg P G, Becquemont L, Verstuyft C, Kotti S, Schiele F, Ferrari E, Drouet E, Grollier G, Danchin |
| Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention. Pharmacogenomics 2011 Sep 12 (9): 1269-80. Rideg Orsolya, Komócsi András, Magyarlaki Tamás, Tokés-Füzesi Margit, Miseta Attila, Kovács Gábor L, Aradi Dáni |
| [Factors determining clinical effectiveness of clopidogrel and prognosis of patients with stable ischemic heart disease]. Kardiologiia 2011 51 (2): 8-18. Komarov A L, Panchenko E P, Donnikov A E, Shakhmatova O O, Dzhalilova G V, Iliushchenko T |
| Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome. Journal of the American College of Cardiology 2011 Jun 57 (25): 2474-83. Campo Gianluca, Parrinello Giovanni, Ferraresi Paolo, Lunghi Barbara, Tebaldi Matteo, Miccoli Matteo, Marchesini Jlenia, Bernardi Francesco, Ferrari Roberto, Valgimigli Mar |
| Predicting clopidogrel response using DNA samples linked to an electronic health record. Clinical pharmacology and therapeutics 2011 Dec . Delaney JT, Ramirez AH, Bowton E, Pulley JM, Basford MA, Schildcrout JS, Shi Y, Zink R, Oetjens M, Xu H, Cleator JH, Jahangir E, Ritchie MD, Masys DR, Roden DM, Crawford DC, Denny JC |
| Effect of CYP2C19*2 and *3 loss-of-function alleles on platelet reactivity and adverse clinical events in East Asian acute myocardial infarction survivors treated with clopidogrel and aspirin. Circulation. Cardiovascular interventions 2011 Dec 4 (6): 585-94. Jeong Young-Hoon, Tantry Udaya S, Kim In-Suk, Koh Jin-Sin, Kwon Tae Jung, Park Yongwhi, Hwang Seok-Jae, Bliden Kevin P, Kwak Choong Hwan, Hwang Jin-Yong, Gurbel Paul |
| Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study. British journal of clinical pharmacology 2012 Apr 73 (4): 629-40. Kim In-Suk, Jeong Young-Hoon, Park Yongwhi, Yoon Seong-Eun, Kwon Tae Jung, Park Jeong Rang, Hwang Seok-Jae, Koh Eun-Ha, Kwak Choong Hwan, Hwang Jin-Yong, Kim Sunj |
| Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction. International journal of cardiology 2013 Sep 167 (6): 2882-8. Verschuren Jeffrey J W, Boden Helèn, Wessels Judith A M, van der Hoeven Bas L, Trompet Stella, Heijmans Bastiaan T, Putter Hein, Guchelaar Henk-Jan, Schalij Martin J, Jukema J Wout |
| CYP2C19*2/ABCB1-C3435T polymorphism and risk of cardiovascular events in coronary artery disease patients on clopidogrel: is clinical testing helpful? Indian heart journal 2012 64 (4): 4. Singh M, Shah T, Adigopula S, Molnar J, Ahmed A, Khosla S, Arora R |
| Effect of the CYP2C19 2 and 3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention. European journal of clinical pharmacology 2012 Nov . Tang XF, Wang J, Zhang JH, Meng XM, Xu B, Qiao SB, Wu YJ, Chen J, Wu Y, Chen JL, Gao RL, Yuan JQ, Yang YJ |
| The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2013 Jul 9 (3): 316-27. Liang Zhen-Yang, Han Ya-Ling, Zhang Xiao-Lin, Li Yi, Yan Cheng-Hui, Kang Ji |
| Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genes. Thrombosis and haemostasis 2013 Jan 109 (4): 4. Carlquist JF, Knight S, Horne BD, Huntinghouse JA, Rollo JS, Muhlestein JB, May H, Anderson JL |
| [Clopidogrel metabolism related gene polymorphisms in Chinese patients with acute coronary syndrome]. Zhonghua xin xue guan bing za zhi 2012 Nov 40 (11): 11. Feng GX, Liang Y, Bai Y, Chen T, Liu X, Yang YM, Wang XY, Yang YJ, Zhu J |
| ABCB1 C3435T polymorphism and the risk of coronary heart disease: a meta-analysis. Genetic testing and molecular biomarkers 2014 Mar 18 (3): 164-73. Jin Yuanzhe, Wang Qi, Wang Guofeng, Zhang Xueying, Yan Bin, Hu Wei |
| Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease. JACC. Cardiovascular interventions 2013 Nov 6 (11): 11. Viviani Anselmi C, Briguori C, Roncarati R, Papa L, Visconti G, Focaccio A, De Micco F, Latronico MV, Pagnotta P, Condorelli G |
| Relationship between ABCB1 polymorphisms, thromboelastography and risk of bleeding events in clopidogrel-treated patients with ST-elevation myocardial infarction. Thrombosis research 2014 Nov 134 (5): 970-5. Zhang Jia-Hui, Tang Xiao-Fang, Zhang Yin, Wang Jing, Yao Yi, Ma Yuan-Liang, Xu Bo, Gao Run-Lin, Gao Zhan, Chen Jue, Song Lei, Wu Yuan, Meng Xian-Min, Yuan Jin-Qi |
| ABCB1 C3435T polymorphism and the risk of ischemic heart disease: a meta-analysis. Genetic testing and molecular biomarkers 2014 Sep 18 (9): 636-45. Wang Qi, Jin Yuan-Zhe, Zhou Shao-Bo, Wang Li-Jie, Lei Ming-Ming, Wang Yong, Miao C |
| A prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI study. The pharmacogenomics journal 2015 Apr . So D Y F, Wells G A, McPherson R, Labinaz M, Le May M R, Glover C, Dick A J, Froeschl M, Marquis J-F, Gollob M H, Tran L, Bernick J, Hibbert B, Roberts J |
| P-Glycoprotein Polymorphism C3435T Is Associated with Dose-Adjusted Clopidogrel and 2-Oxo-Clopidogrel Concentration. Pharmacology 2015 Dec 97 (3-4): 101-106. Stokanovic Dragana, Nikolic Valentina N, Konstantinovic Sandra S, Zvezdanovic Jelena B, Lilic Jelena, Apostolovic Svetlana R, Pavlovic Milan, Zivkovic Vladimir S, Jevtovic-Stoimenov Tatjana, Jankovic Slobodan |
| Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) programme. European heart journal 2015 Nov . Puymirat Etienne, Lamhaut Lionel, Bonnet Nicolas, Aissaoui Nadia, Henry Patrick, Cayla Guillaume, Cattan Simon, Steg Gabriel, Mock Laurent, Ducrocq Gregory, Goldstein Patrick, Schiele François, Bonnefoy-Cudraz Eric, Simon Tabassome, Danchin Nicol |
| Interaction of CYP2C19, P2Y12, and GPIIIa Variants Associates With Efficacy of Clopidogrel and Adverse Events on Patients With Ischemic Stroke. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2016 May . Yi Xingyang, Wang Yanfen, Lin Jing, Cheng Wen, Zhou Qiang, Wang Ch |
| [Relationship between ATP-binding cassette subfamily B member 1 and cytochrome P450 2C19 polymorphisms and the effect of clopidogrel post percutaneous coronary intervention in patients with acute coronary syndrome]. Zhonghua xin xue guan bing za zhi 2016 Apr 44 (4): 309-14. Zhou C F, Ren Y H, Song Y Q, Yi J, Han B S, Xue Q, Fu Z H, Li D |
| Results of genotype-guided antiplatelet therapy in patients who undergone percutaneous coronary intervention with stent. International journal of cardiology 2016 Sep 225 289-295. Sánchez-Ramos Jesús, Dávila-Fajardo Cristina Lucía, Toledo Frías Pablo, Díaz Villamarín Xando, Martínez-González Luis Javier, Martínez Huertas Susana, Burillo Gómez Francisco, Caballero Borrego Juan, Bautista Pavés Alicia, Marín Guzmán Mª Carmen, Ramirez Hernández José Antonio, Correa Vilches Concepción, Cabeza Barrera Jo |
| Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect. Frontiers in pharmacology 2017 1 7 494. Ing Lorenzini Kuntheavy, Daali Youssef, Fontana Pierre, Desmeules Jules, Samer Caroli |
| Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes: The PHARMCLO Trial. Journal of the American College of Cardiology 2018 Feb . Notarangelo Francesca Maria, Maglietta Giuseppe, Bevilacqua Paola, Cereda Marco, Merlini Piera Angelica, Villani Giovanni Quinto, Moruzzi Paolo, Patrizi Giampiero, Malagoli Tagliazucchi Guidantonio, Crocamo Antonio, Guidorossi Angela, Pigazzani Filippo, Nicosia Elisa, Paoli Giorgia, Bianchessi Marco, Comelli Mario Angelo, Caminiti Caterina, Ardissino Die |
| Efficacy of P2Y12 Receptor Blockers After Myocardial Infarction and Genetic Variability of their Metabolic Pathways. Current vascular pharmacology 2018 2 17 (1): 35-40. Máchal Jan, Hlinomaz O |
| Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohort. Pharmacogenomics 2018 12 20 (2): 75-83. Melin Kyle, Moon Jee-Young, Qi Qibin, Hernandez-Suarez Dagmar F, Duconge Jorge, Hua Simin, Gonzalez Sara, Zeng Donglin, Kaplan Robert |
| Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study. Scientific reports 2018 1 8 (1): 1229. Joo Hyung Joon, Ahn Sung Gyun, Park Jae Hyoung, Park Ji Young, Hong Soon Jun, Kim Seok-Yeon, Choi WoongGil, Gwon HyeonCheol, Lim Young-Hyo, Kim Weon, Kang Woong Chol, Cho Yun-Hyeong, Kim Yong Hoon, Yoon JungHan, Shin WonYong, Hong Myeong-Ki, Garg Scot, Jang Yangsoo, Lim Do-S |
| The influence of acute coronary syndrome on levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19*2(681 G>A), *3(636 G>A) and ABCB1(C3435C> T) gene polymorphisms. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology 2021 Jun 17 (2): 179-186. Wójcik Tomasz, Karolko Bo?ena, Wi?niewski Jerzy, Mysiak Andrzej, ?ciborski Krzysztof, Onisk Grzegorz, Lebioda Arleta, Jonkisz Anna, Protasiewicz Marc |
| The Effect of Platelet Activity, ABCB1 Genetic Polymorphism, and Renal Function on the Development of Ticagrelor-Related Dyspnea in Patients with Acute Coronary Syndrome. Drug design, development and therapy 2024 1 18 109-119. Vytenis Tamakauskas, Remigijus Žali?nas, Vaiva Lesauskait?, Nora Kupstyt?-Krištapon?, Ieva ?iapien?, Gintar? Šakalyt?, Jurgita Plisien?, Vilius Skipskis, Vacis Tatar?n |
- Page last reviewed:Feb 1, 2024
- Content source: